Let Activefol.io Invest in GILD on Your Behalf.
- Active Investing
- Personalized Strategy
- Low Monthly Fees
Course of Action
Sentiment (10 days)
- Strong Buy
- Strong Sell
DAILY PRICE CHANGE VS SENTIMENT
What Problem Does Activefol.io Solves?
Activefol.io is an advanced automated portfolio management platform designed to provides investors with a reliable partner to automate their strategy. It is designed to screen, monitor and invest in elite stocks like "GILEAD SCIENCES, INC. (GILD)" using Artificial Intelligence, social media, and market data to augments investors potential.
Activefol.io produces short-term trades which makes it an iActivefol.io in a regular brokerage account, you will be taxed at regular income. Make sure you understand your tax situation before using Activefol.io.
Using Activefol.io is easy. It connects to select Broker / Dealers in the United States. All you need to do is open an account, put a minimum of $25,000 in it and start your strategy.
There are clear benefits associated with using an automated investment system such as Activefol.io to help you reach your financial goals. Activefol.io simplifies stock investing down to a few steps. It invests for you, using your personalized strategy, while you attend more important life events.
'Trading on the news' is a technique used by investors to justify buying or selling securities. News reports often spur short-term moves in the market, creating investment opportunities.
Announcements about earnings, product launches, changes in management, all are events that can cause a company's stock price to move up or down.
Digital news sources
Today, news travels through digital means. It reaches social networks at breakneck speed. News can spread virally from the originator to millions of people in a matter of minutes. If the news has material value, it is re-tweeted immediately.
Artificial Intelligence Investing at its best
ACTIVEFOL.IO's proprietary investment system sift through 1000s of news to figure out where the action is. Its screening technology allows the automated portfolio manager to invest based on real intelligence.
With this technology, gone are the days of staring at a Bloomberg terminal for the purpose of identifying trading opportunities. Computers essentially have mastered how to 'trade on the news'.
Algorithmic Wall Street
As of 2009, Wikipedia states that computers who are using events to trigger trades, accounted for 60% of all US stock market trading volume.' In 2018, this phenomenon has ballooned to 85% of all equity trades.
Wall Street's automated strategies have become so pervasive that we can say that the market is about to become fully robotized.
Automated 'trading on the news' brings about a new world of opportunities, where investors will get a better 'bang for their buck' without the need for a traditional Investment Advisor. All they will really need is a brokerage account and access to their favorite auto-trading tool.
Using Activefol.io is like having thousands of spies working for you to help you get the best possible information available.
Activefol.io actively invests which is different from passive investing. It is on the lookout working to maximize your potential every minute of every business day of the year. It trades on the news taking advantage of price changes and trends by listening into trader's communications and by validating this information with market data.
Activefol.io is one of the first automated portfolio management platforms to take advantage of Government grade listening technology, Artificial Intelligence, social media, and market data natively.
Try Activefol.io today!
You can test your strategy in simulation mode, risk free, Stock Circles today.
Get started now - and see where active automated trading can take you.
Disclaimer: Past performance may not be indicative of future results. Activefol.io, like other investment methods, rely on favorable market conditions to provide positive outcomes.
GILEAD SCIENCES, INC. (GILD) News
Gilead Sciences to Present at the Jefferies 2018 Healthcare Conference on Wednesday, June 6
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that John F. Milligan, PhD, Gilead’s President and Chief Executive Officer; Robin L. Washington, Gilead’s Executive Vice President and Chief Financial Officer; John McHutchison, Gilead’s Chief Scientific Officer and Head of Research & Development; and Andrew Cheng, Gilead’s Chief Medical Officer and Executive Vice President, will participate in a fireside chat at the Jefferies 2018 Healthcare Conference in New York on Wednesday, June 6 at 10:30 a.m. Eastern Time.
The audio portion of the fireside chat will be accessible live through the company’s Investors page at www.gilead.com/investors. Please connect to the company’s website at least 15 minutes prior to the start of the presentation to ensure adequate time for any software download that may be required to listen to the webcast. The replay will be available for 14 days following the presentation.Get Started today! - Risk Free